Global office locator

Join us at #CTOWC26, taking place on 28–29 April 2026 in Burlingame, California, where oncology and clinical research professionals will gather to discuss the evolving landscape of oncology clinical trials. ICON Biotech...

Behind every successful oncology programme is experience you can trust. With 11,000+ oncology and haematology specialists, ICON has supported 840+ oncology studies in the past five years and contributed to 47 FDA and EM...

From advanced analytics to integrated oversight, ICON is redefining how clinical data supports confident decision‑making across the product lifecycle. At SCDM #EMEA26, meet the ICON team at booth \#11 to learn how we ar...

ICON Biotech will be onsite at #OCT East Coast, taking place 12–13 May at the Hyatt Regency New Brunswick, New Jersey. Visit us at Booth \#25. Meet the ICON Biotech team to explore how we support biotech sponsors with: ...

The future of HEOR is here and ICON is helping shape it. Join us at #ISPORAnnual to discuss innovative approaches in economic modeling, value demonstration, and market access insights. Stop by Booth \#1017 to meet our t...

Join ICON at EMWA 2026 for a poster presentation on 'AI and Medical Writing: Insights from those on the front line'. Hear from Marina Cimpean, Mauro Meloni, Sara Fernandes, and Rona Grunspan as they share practical pe...

Join Paul Cariola of Symphony Health, an ICON plc company, and Anne Smith of HealthWise Data for a podium presentation at PMSA on how combining real world claims with provider as consumer insights is advancing HCP segmen...

As BIO Korea 2026 approaches, ICON looks forward to joining industry leaders in Seoul from 28 to 30 April. The event remains a key forum for discussing advances in biotechnology, global partnerships and the future of hea...

Reporting results with clarity and consistency Decision makers require accessible, reproducible outputs. The whitepaper explains how evidence networks, forest plots, league tables and rankograms work together to communi...

Parkinson’s disease (PD) is the fastest-growing neurological condition in the world, and recent estimates suggest that the number of people living with Parkinson’s will double to 25 million by the year 2050. Explore how ...

ICON is excited to sponsor RAPS Euro Convergence 2026, taking place 5–8 May in Lisbon. ICON are joining regulatory leaders at RAPS Euro Convergence 2026, taking place 5–8 May in Lisbon. Drop by and meet Gabriel Bohl a...

Pediatric trials face unique complexity but selecting a fit for purpose HRQoL measure doesn’t have to. The FDA’s PFDD Guidance emphasizes that historical use is not justification. Sponsors must demonstrate why an instrum...